Repressed experiments for module 284

Experiment nameClinical attributes
Chen02_HCC_HBV_HK42Hepatocellular carcinoma (Liver cancer), Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), p53 positive hepatocellular carcinoma (Liver cancer), Invasive liver tumor (Liver cancer)
Chen02_HCC_HCV_SF24Hepatocellular carcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Hepatitis C virus (HCV) infected liver (Liver cancer)
Chen02_HCC_HK41Hepatocellular carcinoma (Liver cancer), Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), p53 positive hepatocellular carcinoma (Liver cancer)
Chen02_HCC_HK6Hepatocellular carcinoma (Liver cancer), Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Invasive liver tumor (Liver cancer)
Detweiler01_E2_U937_mock_2hMacrophages (Stimulated immune*), Monocytes (Stimulated immune*), Hematologic samples and cell lines (Stimulated immune*), Hematologic cancer and cell line (Stimulated immune*)
Garber01_220_97_SCCCancer (Lung cancer*), Cancer and cell line (Lung cancer*), Lung tissue, cancer or cell line (Lung cancer*), Lung cancer (Lung cancer*), Non small cell lung cancer (Lung cancer*), Lung cancer or cell line (Lung cancer*), Non small cell lung cancer and cell line (Lung cancer*), Squamous cell lung cancer (Lung cancer)
Perou00_BC107A_AFBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*)
Ramaswamy01_Tumor__Lymphoma_Large_B-Cell_L_B_CELL_S94_17150_RCancer (Various tumors), Cancer and cell line (Various tumors), Cancer (Various tumors*), Cancer and cell line (Various tumors*), Hematologic cancer (Various tumors), B cells (Various tumors), Lymphoma (Various tumors), Lymphocytes (Various tumors), Primary blood mononuclear cells (Various tumors), Monocytes (Various tumors), Hematologic samples (Various tumors), Hematologic samples and cell lines (Various tumors), Hematologic cancer and cell line (Various tumors), Diffuse large B cell lymphoma - DLBCL (Various tumors), Diffuse large B cell lymphoma tumor or cell line (Various tumors)
Ramaswamy01_Tumor__Lymphoma_Large_B-Cell_L_B_CELL_S98_8825_YCancer (Various tumors), Cancer and cell line (Various tumors), Cancer (Various tumors*), Cancer and cell line (Various tumors*), Hematologic cancer (Various tumors), B cells (Various tumors), Lymphoma (Various tumors), Lymphocytes (Various tumors), Primary blood mononuclear cells (Various tumors), Monocytes (Various tumors), Hematologic samples (Various tumors), Hematologic samples and cell lines (Various tumors), Hematologic cancer and cell line (Various tumors), Diffuse large B cell lymphoma - DLBCL (Various tumors), Diffuse large B cell lymphoma tumor or cell line (Various tumors)
Ross00_BT_549_CL5013_BREASTCell line (NCI60*), Cancer and cell line (NCI60*), Breast cancer cell line (NCI60), Female hormonal cancer cell line (NCI60), Breast cancer or cell line (NCI60), Breast tissue, cancer or cell line (NCI60), Female hormonal tissue, cancer or cell line (NCI60)
Ross00_LOXIMVI_CL10001_MELANOMAFast doubling (20-40) cell lines (NCI60), Cell line (NCI60*), Cancer and cell line (NCI60*), Melanoma cell line (NCI60), Melanoma tumor or cell line (NCI60)
Ross00_SK_MEL_2_CL10005_MELANOMACell line (NCI60*), Cancer and cell line (NCI60*), Melanoma cell line (NCI60), Melanoma tumor or cell line (NCI60)
Sorlie01_BC125A_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer)
Sorlie01_BC18Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Grade 3 (Breast cancer)
Sorlie01_BC303B_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Grade 3 (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC405A_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC48_0Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Grade 3 (Breast cancer)
Sorlie01_BC4_LN4Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer)
Sorlie01_BC6Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Grade 3 (Breast cancer)
Sorlie01_BC605B_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Dead prognosis (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC608B_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer)
Sorlie01_BC702B_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer)
Sorlie01_BC706A_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Mutated p53 tumor (Breast cancer)
Staunton01_LEUK_K562Fast doubling (20-40) cell lines (NCI60), Cell line (NCI60*), Cancer and cell line (NCI60*), Leukemia cell line (NCI60), Hematologic samples and cell lines (NCI60), Hematologic cancer and cell line (NCI60)
Staunton01_RENAL_7860Fast doubling (20-40) cell lines (NCI60), Cell line (NCI60*), Cancer and cell line (NCI60*), Renal cancer cell line (NCI60), Renal cancer or cell line (NCI60), Renal tissue (NCI60)
Staunton01_RENAL_TK10Cell line (NCI60*), Cancer and cell line (NCI60*), Renal cancer cell line (NCI60), Renal cancer or cell line (NCI60), Renal tissue (NCI60)